APA (7th ed.) Citation

Holtze, C., Flaherty, K., Kreuter, M., Luppi, F., Moua, T., Vancheri, C., & Scholand, M. B. (2018). Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases. European respiratory review, 27(150), . https://doi.org/10.1183/16000617.0078-2018

Chicago Style (17th ed.) Citation

Holtze, Colin, Kevin Flaherty, Michael Kreuter, Fabrizio Luppi, Teng Moua, Carlo Vancheri, and Mary B. Scholand. "Healthcare Utilisation and Costs in the Diagnosis and Treatment of Progressive-fibrosing Interstitial Lung Diseases." European Respiratory Review 27, no. 150 (2018). https://doi.org/10.1183/16000617.0078-2018.

MLA (9th ed.) Citation

Holtze, Colin, et al. "Healthcare Utilisation and Costs in the Diagnosis and Treatment of Progressive-fibrosing Interstitial Lung Diseases." European Respiratory Review, vol. 27, no. 150, 2018, https://doi.org/10.1183/16000617.0078-2018.